Oliver F Wirz

Dr. Oliver F Wirz

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2019 in European Journal of Immunology
Verified
Journal Article
Open access
ACAndrea Cossarizza
Andrea Cossarizza
HCHyun-Dong Chang
Hyun-Dong Chang
ARAndreas Radbruch
Andreas Radbruch
AAAndreas Acs
Andreas Acs
DADieter Adam
Dieter Adam
AZArturo Zychlinsky
Arturo Zychlinsky
These guidelines are a consensus work of a considerable number of members of the immunology and flow cytometry community. They provide the theory and key practical aspects of flow cytometry enabling immunologists to avoid the common errors that often undermine immunological data. Notably, there are comprehensive sections of all major immune cell types with helpful Tables detailing phenotypes in murine and human cells. The latest flow cytometry techniques and applications are also described, featuring examples of the data that can be generated and, importantly, how the data can be analysed. Furthermore, there are sections detailing tips, tricks and pitfalls to avoid, all written and peer‐reviewed by leading experts in the field, making this an essential research companion.

1 October 2016 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
MAMubeccel Akdis
Mubeccel Akdis
AAAlar Aab
Alar Aab
CACan Altunbulakli
Can Altunbulakli
KAKursat Azkur
Kursat Azkur
RCRita A. Costa
Rita A. Costa
CACezmi A. Akdis
Cezmi A. Akdis

18 December 2020 in Science Immunology
Verified
Journal Article
Open access
KRKatharina Röltgen
Katharina Röltgen
APAbigail E. Powell
Abigail E. Powell
OWOliver F Wirz
Oliver F Wirz
BSBryan A. Stevens
Bryan A. Stevens
CHCatherine A. Hogan
Catherine A. Hogan
SBScott Boyd
Scott Boyd
Illness severity in COVID-19 correlates with specificity of serological responses, but antibody levels decrease in most patients.

1 September 2016 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
WVWillem van de Veen
Willem van de Veen
BSBarbara Stanic
Barbara Stanic
OWOliver F Wirz
Oliver F Wirz
KJKirstin Jansen
Kirstin Jansen
AGAnna Globinska
Anna Globinska
MAMubeccel Akdis
Mubeccel Akdis

1 May 2021 in EBioMedicine
Verified
Journal Article
Open access
TTThao T. Truong
Thao T. Truong
ARAlex Ryutov
Alex Ryutov
UPUtsav Pandey
Utsav Pandey
RYRebecca Yee
Rebecca Yee
LGLior Goldberg
Lior Goldberg
JBJennifer Dien Bard
Jennifer Dien Bard
There is increasing concern that persistent infection of SARS-CoV-2 within immunocompromised hosts could serve as a reservoir for mutation accumulation and subsequent emergence of novel strains with the potential to evade immune responses. We describe three patients with acute lymphoblastic leukemia who were persistently positive for SARS-CoV-2 by real-time polymerase chain reaction. Viral viability from longitudinally-collected specimens was assessed. Whole-genome sequencing and serological studies were performed to measure viral evolution and evidence of immune escape. We found compelling evidence of ongoing replication and infectivity for up to 162 days from initial positive by subgenomic RNA, single-stranded RNA, and viral culture analysis. Our results reveal a broad spectrum of infectivity, host immune responses, and accumulation of mutations, some with the potential for immune escape. Our results highlight the potential need to reassess infection control precautions in the management and care of immunocompromised patients. Routine surveillance of mutations and evaluation of their potential impact on viral transmission and immune escape should be considered.

1 March 2015 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
BSBarbara Stanic
Barbara Stanic
WVWillem van de Veen
Willem van de Veen
OWOliver F Wirz
Oliver F Wirz
BRBeate Rückert
Beate Rückert
HMHideaki Morita
Hideaki Morita
MAMubeccel Akdis
Mubeccel Akdis